Newsroom

In some territories, which are listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside of those territories our devices are supplied for research use only (RUO).

Trajan Licenses Technology to Develop Microbiopsy Device

by Neoteryx, on April 19,2022

Trajan Licenses Technology to Develop Microbiopsy Device

April 2022 — Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland (UQ) to develop a portable skin microbiopsy device that takes tissue samples smaller …

Read Story

Neoteryx Releases New Tech Guide on Dried Sample Storage

by Neoteryx, on February 14,2022

Neoteryx Releases New Tech Guide on Dried Sample Storage

February 2022 — Device company Neoteryx, which is now part of the Trajan Scientific and Medical family, announces the release of a new tech note for research customers that use …

Read Story

Trajan Group Holdings Limited Acquires Neoteryx

by Neoteryx, on January 11,2022

Trajan Group Holdings Limited Acquires Neoteryx

January 2022 – As announced by Trajan Group Holdings Limited (ASX: TRJ) in early January from their headquarters in Australia, the company has acquired microsampling leader Neoteryx LLC. As reported …

Read Story

Neoteryx Tailors Mitra Collection Kits for Kids

by Neoteryx, on December 1,2021

Neoteryx Tailors Mitra Collection Kits for Kids

December 2021 — US-based medical device company Neoteryx announces its user-friendly at-home specimen collection kit for children in support of labs and research customers that conduct pediatric studies, clinical trials …

Read Story

Brazil Registers Neoteryx’s Mitra Devices for Specimen Collection

by Neoteryx, on November 16,2021

Brazil Registers Neoteryx’s Mitra Devices for Specimen Collection

November 2021 — The Mitra® microsampling device from US-based Neoteryx has been registered in Brazil as a Class 1 in vitro diagnostic (IVD) medical device by ANVISA, the Agência Nacional …

Read Story
Prev All Posts Next
Content not found

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs
Neoteryx Experts

Media Contacts
Media Assets
Scientific Research Publications

social media

subscribe to news

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Neoteryx, LLC

© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501

This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.

part-of-trajan-family-logo-white-text

 

Get To Know Us

Follow Us

Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC. 

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.  

Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.